|
Companies with Certified Existing Treatments for Swine Flu
Gilead Sciences, Inc. (NASDAQ:GILD)
Roche Holding Ltd. (OTC:RHHBY)
Product: Tamiflu (oseltamivir)
GlaxoSmithKline plc (NYSE:GSK) /
Biota Holdings Ltd.(ASX:BTA)
Product: Relenza (zanamivir)
Baxter International Inc. (NYSE: BAX)
Product: A(H1N1) vaccine using its Vero cell culture technology
Novartis AG (NYSE:NVS)
Product: Influenza A(H1N1) vaccine using Cell-based manufacturing technology
Companies with Potential Treatments for Swine Flu
CEL-SCI Corporation (Amex: CVM)
Product: proprietary L.E.A.P.S. technology (Ligand Epitope Antigen Presentation System)
Companies with Potential Vaccines
for Swine Flu
Biota Holdings Ltd.(ASX:BTA) /
Daiichi Sankyo
Product: CS-8958
BioCryst Pharmaceuticals,Inc. (NASDAQ:BCRX)
Product: Peramivir Intravenous
Novavax, Inc. (NASDAQ:NVAX)
Product: Swine Flu Vaccines
using Virus-like particle (VLP) technology
Inovio Biomedical Corporation (NYSE Amex:INO)
Product: SynCon™ H1N1 influenza DNA vaccines
Vical Incorporated(Public, NASDAQ:VICL)
Product: Patented DNA delivery technology
Sinovac Biotech Ltd. (Amex: SVA)
Product: Panflu(TM)
Wyeth (NYSE: WYE)
Product: PCV13 or Prevnar 13
MedImmune / AstraZeneca PLC (NYSE:AZN)
Product: needle-free, nasal spray swine flu vaccine by using Live Attenuated Influenza Vaccine (LAIV) technology
Sanofi-Aventis SA (NYSE:SNY)
Product: Swine Flu Vaccine
Companies with Adjuvants
for Swine Flu Vaccines
Antigenics, Inc. (NASDAQ:AGEN)
Product: QS-21 Stimulon
Hemispherx Biopharma (AMEX:HEB)
Product: Ampligen
Other Technologies
Which Combat H1N1
Oculus Innovative Sciences, Inc.
(NASDAQ:OCLS)
Microcyn® Technology platform
|
